VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 112 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,717,000 | -38.6% | 533,332 | 0.0% | 2.34% | -47.5% |
| Q4 2021 | $22,331,000 | -3.8% | 533,332 | 0.0% | 4.45% | -5.6% |
| Q3 2021 | $23,211,000 | -8.0% | 533,332 | 0.0% | 4.71% | +21.1% |
| Q2 2021 | $25,216,000 | -7.8% | 533,332 | 0.0% | 3.89% | -24.7% |
| Q1 2021 | $27,344,000 | +64.1% | 533,332 | -14.3% | 5.16% | +110.2% |
| Q4 2020 | $16,663,000 | -22.0% | 622,221 | 0.0% | 2.46% | -25.7% |
| Q3 2020 | $21,361,000 | -16.2% | 622,221 | 0.0% | 3.30% | -27.2% |
| Q2 2020 | $25,492,000 | – | 622,221 | – | 4.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |